Call for Papers | 2026 Conference on Clinical and Translational Hematology (CTH 2026)

To strengthen global academic exchanges in the field of hematology, facilitate the in-depth advancement of basic research, translational studies, and clinical investigations related to hematology, and provide a professional platform for sharing knowledge among hematologists, we are delighted to announce that the 2026 Conference on Clinical and Translational Hematology will be held from September 18th to 19th, 2026.

Established in 1887, Chinese Medical Journal (CMJ) is a peer-reviewed, open-access journal dedicated to technical advances, clinical research, health topics, and ethical and social issues in medicine and related fields. The journal is published semimonthly in both print and online formats, with the aim of reporting cutting-edge developments in medical science and technology and promoting international academic exchange. All articles are freely available to readers under an open access policy.

An open call for submissions to the 2026 Conference on Clinical and Translational Hematology has been extended for hematology medical professionals (as first authors) under 45 years old. Outstanding papers will have the opportunity to be presented at this conference and will be preferentially published in the Chinese Medical Journal.

I.The call for papers and related details are as follows:

1. English abstracts should be ~1000 words. Please note that submissions outside this word count will not be uploaded to the system. Structured abstracts must include four sections: Objective, Methods, Results, and Conclusion.

2. Manuscripts should be scientifically rigorous, focused, data-driven, and logically concluded, with clear language.

3. Submission should preferably be unpublished work not previously presented at national academic conferences.

4. Authors should accurately fill in their full name(s), affiliation(s), postal code, and email address(es) in the submission system, and clearly indicate the abstract presenter.

5. Online submissions can be made via the conference website (https://cth2026.tiemeeting.com/Contents/46269.html

) in English. Please note that email and postal submissions will not be accepted.

6. The Instructions for Authors can be found at: https://edmgr.ovid.com/cmj/accounts/ifauth.htm

II.Suggested Topics：

Epidemiological, basic, and clinical research on hematology

Experimental hematology research

Diagnosis of hematologic diseases

Targeted therapy for hematologic malignancies

Hematopoietic stem cell transplantation

Immune cell therapy

Stem cells and bone marrow microenvironment

Vascular biology and immunology

Whole-course management of patients with hematologic diseases

III.Important Dates：

Online Submission Opens: May 20th, 2026.

Online Submission Deadline: August 20th, 2026.

Notification of Abstract Acceptance: August 31st, 2026.